FDA Drug Application (202294) for DEXLANSOPRAZOLE by PAR PHARM INC

Back to FDA Applications sponsored by PAR PHARM INC

Application Number202294
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEXLANSOPRAZOLE
Active IngredientDEXLANSOPRAZOLE



Back to FDA Applications sponsored by PAR PHARM INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.